Safety and Efficacy of Itraconazole Compared to Amphotericin B as Empirical Antifungal Therapy for Neutropenic Fever in Patients with Haematological Malignancy*

By  

Oncology Research and Treatment, Vol. 30, Iss. 4, 2007-03 ,pp. : 185-191

Karger

Access to resources Recommend Favorite

Prophylactic Application of Nebulized Liposomal Amphotericin B in Hematologic Patients with Neutropenia

By  

Oncology Research and Treatment, Vol. 34, Iss. 5, 2011-04 ,pp. : 254-258

Karger

Access to resources Recommend Favorite

Cost-Benefit Assessment of Antifungal Prophylaxis with Liposomal Amphotericin B in Neutropenic Patients

By  

Oncology Research and Treatment, Vol. 30, Iss. 12, 2007-11 ,pp. : 621-626

Karger

Access to resources Recommend Favorite

Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: Fluconazole, liposomal amphotericin B, caspofungin, and voriconazole

By Manfredi Roberto   Sabbatani Sergio  

Scandinavian Journal of Infectious Diseases, Vol. 38, Iss. 10, 2006-10 ,pp. : 950-951

Informa Healthcare

Access to resources Recommend Favorite

Economic analysis of micafungin versus liposomal amphotericin B for treatment of candidaemia and invasive candidiasis in Germany

By Cornely O. A.   Sidhu M.   Odeyemi I.   van Engen A. K.   van der Waal J. M.   Schoeman O.  

Current Medical Research and Opinion, Vol. 24, Iss. 6, 2008-06 ,pp. : 1743-1753

Informa Healthcare

Access to resources Recommend Favorite